Ventas, Inc. - VTR STOCK NEWS

Ventas, Inc. (NYSE: VTR) announced the withdrawal of proxy fight candidate Jonathan Litt from its 2022 Annual Meeting scheduled for April 27, 2022. This follows Land & Buildings' earlier withdrawal of another nominee, Michelle Applebaum. Ventas expressed appreciation for shareholder engagement and highlighted its strong asset portfolio catering to the aging population. The company encourages shareholders to vote 'FOR ALL' nominees on the WHITE proxy card, aiming for continued growth in the senior housing sector.

Land & Buildings Investment Management, a major shareholder of Ventas, Inc. (VTR), has issued a statement regarding its campaign focused on improving the company’s performance. They claim to have received support from many shareholders on identifying existing problems and proposed solutions aimed at restoring Ventas's blue-chip REIT status. However, due to challenges from proxy advisory firms, they are withdrawing their director nomination. Land & Buildings remains a significant shareholder and is keen on the Board's actions to enhance performance.

Ventas, Inc. (NYSE: VTR) will release its Q1 2022 earnings on May 5, 2022, after market close, followed by a conference call on May 6, 2022, at 10:00 a.m. ET. The call is accessible via dial-in or live webcast on the company's Investor Relations website. Ventas, a leading REIT, owns over 1,200 properties across North America and the UK, capitalizing on the growing demand from the aging population. The company focuses on senior living, life sciences, and healthcare real estate, emphasizing diversification and sustainability in its long-term strategy.

Ventas, Inc. (NYSE: VTR) has issued a letter urging shareholders to vote "FOR ALL" of its directors using the WHITE proxy card in connection with the upcoming virtual annual meeting on April 27, 2022. The independent directors express confidence in the Board's performance and emphasize their commitment to shareholder value, highlighting their management of over 1,200 properties. They advocate for re-election of Presiding Director Denny Shelton, citing his operational expertise and successful history in the healthcare sector. Shareholders are encouraged to read the definitive proxy statement for detailed information.

Land & Buildings Investment Management has criticized Ventas for underperformance, urging shareholders to support nominee Jonathan Litt in the upcoming board election. A report from Institutional Shareholder Services (ISS) highlighted Ventas’ poor total shareholder return (TSR) compared to Welltower, indicating a significant valuation gap. ISS acknowledged the need for a shareholder representative on the board to enhance accountability. Additionally, the appointment of Michael Embler was deemed antagonistic, raising concerns about board credibility.

Ventas, Inc. (NYSE: VTR) has mailed a letter urging shareholders to vote 'FOR ALL' of its experienced directors using the WHITE proxy card ahead of its virtual 2022 Annual Meeting on April 27, 2022. Shareholders of record as of March 21, 2022, are eligible to vote. The company emphasizes its commitment to shareholder value through strong capital allocation and proactive responses to the COVID-19 pandemic. Ventas boasts a total shareholder return of over 20% since 1999. However, it faces a proxy contest initiated by Land & Buildings, which seeks to replace a director with its nominee, Jonathan Litt.

Ventas, Inc. (NYSE: VTR) has released a presentation for its 2022 Annual Meeting, scheduled for April 27, 2022. The company highlights a Year-To-Date Total Shareholder Return (TSR) of 23% through March 25, 2022, with an annualized TSR exceeding 20% since 1999. Ventas emphasizes its diversified portfolio and disciplined capital allocation strategy, positioning itself for growth in senior housing. The Board recommends shareholders vote “FOR ALL” directors on the WHITE proxy card, asserting that a challenge from Land & Buildings' nominee lacks substantial merit.

Ventas, Inc. (NYSE: VTR) has announced its participation in the Credit Suisse Healthcare REIT Summit on April 5, 2022. Management will engage in investor meetings and will provide written materials on its website that morning. Ventas operates over 1,200 properties across the U.S., Canada, and the UK, focusing on healthcare and real estate. The company leverages its capital to enhance senior living communities and healthcare facilities, emphasizing diversification and sustainable growth strategies. More information will be archived on their website.

Ventas has filed definitive proxy materials with the SEC for its 2022 Annual Meeting of Stockholders on April 27, 2022. Shareholders as of March 21, 2022, can vote using the WHITE proxy card. Ventas reported a year-to-date total shareholder return (TSR) of 23% as of March 25, 2022, the highest among its peers. The company is poised to benefit from demographic trends and a recovering senior housing market. The Board urges shareholders to vote "FOR ALL" director nominees, rejecting Land & Buildings' nominee Jonathan Litt, whom they deemed unqualified.